Advanced Urothelial Carcinoma: Overcoming Treatment Resistance through Novel Treatment Approaches
The current standard of care for metastatic urothelial carcinoma is cisplatin-based chemotherapy but treatment is generally not curative. Mechanisms of resistance to conventional cytotoxic regimens include tumor cell drug efflux pumps, intracellular anti-oxidants, and enhanced anti-apoptotic signali...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Frontiers Media S.A.
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565214/ |